Vaidyane Ayurved Laboratories's total inventories for the quarter that ended in Mar. 2026 was ₹36 Mil. Vaidyane Ayurved Laboratories's average total inventories from the quarter that ended in Sep. 2025 to the quarter that ended in Mar. 2026 was ₹35 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Vaidyane Ayurved Laboratories's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was ₹12.97.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Vaidyane Ayurved Laboratories's Days Inventory for the
six
months ended in Mar. 2026 was 60.39.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vaidyane Ayurved Laboratories's Inventory Turnover for the quarter that ended in Mar. 2026 was 3.02.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vaidyane Ayurved Laboratories's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.06.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
Vaidyane Ayurved Laboratories's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vaidyane Ayurved Laboratories's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
Vaidyane Ayurved Laboratories Total Inventories Related Terms
Vaidyane Ayurved Laboratories Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vaidyane Ayurved Laboratories Total Inventories Chart
Vaidyane Ayurved Laboratories Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) has a Total Inventories of ₹36 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for Vaidyane Ayurved Laboratories and its competitors.
Is Vaidyane Ayurved Laboratories' Total Inventories too high?
Vaidyane Ayurved Laboratories' current Total Inventories is ₹36 Mil. Overall, Vaidyane Ayurved Laboratories has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Vaidyane Ayurved Laboratories' Total Inventories compare to ZTS and UTHR?
Vaidyane Ayurved Laboratories' Total Inventories of ₹36 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Drug Manufacturers company?
A good Total Inventories depends on the Drug Manufacturers industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Vaidyane Ayurved Laboratories and its competitors. Vaidyane Ayurved Laboratories's current Total Inventories is ₹36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vaidyane Ayurved Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹216.94, compared to a current price of ₹180.60 — trading 16.8% below its estimated fair value. The current Total Inventories is ₹36 Mil. Vaidyane Ayurved Laboratories' overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG), the current Total Inventories is ₹36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vaidyane Ayurved Laboratories (NSE:MADHAVBAUG) Overvalued in 2026?
Based on GuruFocus' analysis, Vaidyane Ayurved Laboratories stock appears to be undervalued.
The current stock price of ₹180.60 is trading 16.8% below its estimated GF Value™ of ₹216.94.
GuruFocus considers Vaidyane Ayurved Laboratories to be Modestly Undervalued.
Key valuation signals for NSE:MADHAVBAUG:
Total Inventories: ₹36 Mil
GF Value™: ₹216.94 vs. price of ₹180.60 (16.8% below fair value)
No single metric tells the full story. See the NSE:MADHAVBAUG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vaidyane Ayurved Laboratories Business Description
Vaidya Sane Ayurved Laboratories Ltd is a medical service institution. The company engaged in research and development in Ayurvedic Medicines and the sale of Ayurvedic medicines & products through its various franchises and own clinics. The Company is also engaged in providing Ayurved medical professional services across its various clinics, including panchkarma and other Ayurvedic treatments through the running of an Ayurvedic Hospital. The company mainly offers treatment for health disease reversal, diabetes reversal, BP management, obesity management, and knee pain relief. The company's business is divided into three segments, i.e., Hospital Activity, Sale of Product, and Common. It derives maximum revenue from the sale of Products.
81GF Score
Get the complete analysis for NSE:MADHAVBAUG
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:MADHAVBAUG has been successfully added to your 
